secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2026-04-01T23:59:59+00:00
Accession:  0001628280-26-022824
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Senti Biosciences to form holding company via tax-free merger; stock to trade as SNTI
--------------------------------------------------------------------------------

- Holding company reorganization effective April 16, 2026 via merger into Senti Biosciences Holdings.
- Each share of common stock automatically converts into one share of holding company common stock with same rights.
- No stockholder vote or action required; no gain/loss recognized for U.S. federal income tax purposes.
- New holding company will have same directors, officers, assets, and operations as current company.
- Stock continues trading on Nasdaq under SNTI with a new CUSIP number.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000162828026022824/0001628280-26-022824-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000162828026022824/snti-20260401.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-022824

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer